We may earn an affiliate commission when you visit our partners.
Course image
Radwan Derbala

The course provides the basics of cell signaling and how the cell division is controlled in the multicellular organisms. The course discusses each signaling pathway and the targeted therapies developed for it. Importantly, the course focuses on delivering the real-life examples from clinical trials so that the participant can have a robust idea on the benefits that the targeted therapies provide while being aware of the challenges that face the medical field. The participant at the end of the course has to know that there is no silver bullet for all cancers, not only that but also how the pharmaceutical industry shifted their focus from the histological segmentation of patients to the genomic one, which then rewarded them with better results and more drug approvals that tend to reach up to 40% from total fda approved drugs each year. Last but not least, the participant in that course will get familiar with several side effects of the inhibition of certain pathways, and how the same pathway can lead to different outcomes in different cell types.

Read more

The course provides the basics of cell signaling and how the cell division is controlled in the multicellular organisms. The course discusses each signaling pathway and the targeted therapies developed for it. Importantly, the course focuses on delivering the real-life examples from clinical trials so that the participant can have a robust idea on the benefits that the targeted therapies provide while being aware of the challenges that face the medical field. The participant at the end of the course has to know that there is no silver bullet for all cancers, not only that but also how the pharmaceutical industry shifted their focus from the histological segmentation of patients to the genomic one, which then rewarded them with better results and more drug approvals that tend to reach up to 40% from total fda approved drugs each year. Last but not least, the participant in that course will get familiar with several side effects of the inhibition of certain pathways, and how the same pathway can lead to different outcomes in different cell types.

The course will discuss only the In addition, the course will discuss several well known oncogenic mutations in the receptors and their targeted therapies.

Enroll now

What's inside

Learning objectives

  • Understand the basics of cell signaling
  • Understand the mapk pathway and the targeted therapies developed for it
  • Understand the pi3k pathway and the targeted therapies developed for it
  • Understand the targeted therapies related to the tumor microenvironment

Syllabus

Course System
Course Syllabus
Disclaimer and References
Revision on Basics
Read more

This course was brought to you by : Radwan Derbala
Participated in Montage : Mostafa Saad

Participated in some designs: Radwa Omar

Traffic lights

Read about what's good
what should give you pause
and possible dealbreakers
Explores targeted therapies, which are increasingly important in cancer treatment and drug development
Focuses on real-life examples from clinical trials, providing practical insights into the benefits and challenges of targeted therapies
Discusses the shift from histological to genomic segmentation of patients, reflecting a modern approach in pharmaceutical research and drug approval processes
Examines the side effects of pathway inhibition, which is crucial for understanding the complexities of targeted cancer therapies
Covers multiple signaling pathways, including MAPK, PI3K, TGF-Beta, NF-KB, JAK-STAT, and WNT-Beta Catenin, offering a comprehensive overview
Includes discussion of tumor microenvironment-related therapies and immune checkpoint inhibitors, which are cutting-edge approaches in cancer treatment

Save this course

Create your own learning path. Save this course to your list so you can find it easily later.
Save

Reviews summary

Deep dive into cancer targeted therapies

According to learners, this course provides a comprehensive overview of cancer signaling pathways and the targeted therapies developed for them. Students particularly appreciate the focus on real-life examples from clinical trials, finding the content relevant and up-to-date. While generally well-received for its clarity and the instructor's knowledge, some reviewers note that a strong prior background in biology is beneficial. Although it serves as an excellent introduction, a few mention that the course may lack the depth required for advanced learners or experts already in the field, suggesting it functions best as a foundational resource.
Serves as a strong introduction, not deep dive.
"This course is a great starting point for understanding cancer signaling."
"For someone new to the field, this provides an excellent foundation."
"As an experienced researcher, I found some parts were a bit too basic for my needs."
Complex topics are explained with clarity.
"The instructor explained difficult concepts like the MAPK and PI3K pathways very clearly."
"Even though the subject is complex, the lectures were easy to follow."
"Appreciated how well the course broke down the molecular mechanisms."
Focuses on practical, real-world applications.
"The focus on clinical trials and real-life examples was incredibly valuable."
"Learning about the targeted therapies currently in use made the material highly relevant."
"The information about the shift to genomic segmentation was particularly insightful for my work."
Covers essential signaling pathways and therapies.
"The course provided a comprehensive overview of the key signaling pathways involved in cancer."
"I gained a solid understanding of multiple targeted therapies for different pathways."
"Excellent coverage of topics ranging from basics to specific treatments."
Prior knowledge in biology is helpful.
"Coming into this, I realized a strong background in molecular biology is definitely needed."
"While the course touches on basics, it moves quickly assuming some prior knowledge."
"Recommended for those with at least an undergraduate level understanding of cell biology."

Activities

Be better prepared before your course. Deepen your understanding during and after it. Supplement your coursework and achieve mastery of the topics covered in Cancer Signaling Pathways and Targeted Therapy with these activities:
Review Cell Biology Basics
Strengthen your understanding of fundamental cell biology concepts to better grasp the complexities of cancer signaling pathways.
Browse courses on Cell Signaling
Show steps
  • Review key concepts in cell structure and function.
  • Study the basics of signal transduction pathways.
  • Practice identifying cellular components and their roles.
Read 'The Emperor of All Maladies: A Biography of Cancer'
Gain a historical perspective on cancer research and treatment to appreciate the significance of targeted therapies.
Show steps
  • Obtain a copy of 'The Emperor of All Maladies'.
  • Read the book, focusing on the historical development of cancer therapies.
  • Reflect on how past challenges have shaped current approaches.
Create a Glossary of Cancer Signaling Terms
Solidify your understanding of key terminology by compiling a glossary of cancer signaling terms encountered in the course.
Show steps
  • Identify key terms related to cancer signaling pathways.
  • Define each term in your own words.
  • Organize the terms alphabetically for easy reference.
Four other activities
Expand to see all activities and additional details
Show all seven activities
Explore Online Resources on Specific Pathways
Deepen your understanding of specific signaling pathways by exploring online tutorials and resources.
Show steps
  • Choose a specific signaling pathway (e.g., MAPK, PI3K).
  • Search for online tutorials, videos, and interactive resources.
  • Take notes on key concepts and mechanisms.
Design a Presentation on a Targeted Therapy
Apply your knowledge by creating a presentation on a specific targeted therapy, including its mechanism of action and clinical applications.
Show steps
  • Select a targeted therapy discussed in the course.
  • Research the therapy's mechanism of action and clinical trial data.
  • Create a presentation summarizing your findings.
  • Practice delivering the presentation.
Review 'Hallmarks of Cancer: The Next Generation'
Gain a deeper understanding of the fundamental characteristics of cancer cells and how they relate to targeted therapies.
Show steps
  • Obtain a copy of 'Hallmarks of Cancer: The Next Generation'.
  • Read the book, focusing on the hallmarks relevant to the course.
  • Relate the hallmarks to specific signaling pathways and targeted therapies.
Write a Blog Post on a Clinical Trial
Reinforce your understanding of clinical trials by writing a blog post summarizing the results of a recent study on a targeted therapy.
Show steps
  • Select a recent clinical trial on a targeted therapy.
  • Read the published study and summarize the key findings.
  • Write a blog post explaining the trial's significance.

Career center

Learners who complete Cancer Signaling Pathways and Targeted Therapy will develop knowledge and skills that may be useful to these careers:
Research Scientist
Research Scientists design and conduct experiments to advance scientific knowledge, often in specialized fields like cancer biology. As a Research Scientist, this course focusing on cancer signaling pathways and targeted therapies provides a strong foundation. The course's detailed exploration of pathways like EGFR, MAPK, and PI3K helps build expertise in cancer cell signaling. The coverage of oncogenic mutations and their targeted therapies is directly relevant to developing new research directions. In addition, the course's discussion of the tumor microenvironment is important for research scientists to understand, as it plays a critical role in cancer progression and treatment response. A deeper understanding of the challenges in the medical field helps one design research to overcome those challenges. This course will enable one to focus on the signaling pathways and mutations that need more targeted therapies.
Medical Science Liaison
A Medical Science Liaison acts as a bridge between pharmaceutical companies and healthcare professionals, often specializing in a therapeutic area like oncology. If you seek a role as Medical Science Liaison, the course's focus on cancer signaling pathways and targeted therapies provides essential knowledge. The course delves into the specifics of various pathways like MAPK and PI3K, equipping you with a deep understanding of how targeted therapies work at the molecular level. This course is particularly well-suited for this role since it discusses real-life examples from clinical trials of targeted therapies. As a Medical Science Liaison working with cancer treatments, you will be able to clearly communicate the science behind new therapies and answer difficult questions from cancer specialists in the medical community. The course's discussion of tyrosine kinase receptors, C-Met receptors, ALK receptors, and FGFR receptors will be particularly relevant.
Bioinformatics Analyst
Bioinformatics Analysts analyze biological data, often using computational tools and databases, to identify patterns and insights relevant to disease or drug development. If you are interested in becoming a Bioinformatics Analyst, the course's focus on cancer signaling pathways and targeted therapies provides a relevant context for analyzing genomic and proteomic data. The knowledge of oncogenic mutations and their targeted therapies is crucial for interpreting the results of genomic sequencing and other high-throughput experiments. Also, the course can help you understand the challenges in the medical field. The discussion of genomic patient segmentation and its impact on drug approvals can help you identify potential biomarkers for predicting treatment response. The sections on signaling pathways like EGFR, MAPK, and PI3K can help you create predictive models for drug response and resistance.
Genetics Counselor
Genetic counselors assess individual or family risk for inherited conditions, interpret genetic test results, and provide education and support. This role typically requires a master's degree. For those desiring to become Genetics Counselor, this course focusing on cancer signaling pathways and targeted therapies provides a great foundation for understanding the genomic basis of cancer and how it informs treatment decisions. The course's detailed exploration of pathways like EGFR, MAPK, and PI3K helps one clearly explain the mechanisms of cancer development to patients. Also, the real-life examples from clinical trials of targeted therapies can be used to illustrate the benefits and limitations of precision medicine approaches. You will also better understand the shift towards genomic patient segmentation and its impact on drug approvals. You will be able to use the information about immune checkpoint inhibitors and their clinical applications in your daily work with families and individuals.
Biotechnology Research Associate
A Biotechnology Research Associate supports research activities in biotechnology companies, often working on projects related to drug development or disease mechanisms. For those seeking to become a Biotechnology Research Associate, the course may be useful due to its emphasis on cell signaling, tumorigenesis, and targeted therapies. The course's curriculum covers all the things one needs to understand the current direction of cancer therapeutics. The material on specific signaling pathways and oncogenic mutations is highly relevant to research in this area. This course gives someone who is looking at the field of cancer research a head start. The course's information on immune checkpoint inhibitors and their clinical applications can help one be a more well-rounded professional.
Medical Writer
Medical Writers create documents related to healthcare, such as clinical study reports, regulatory submissions, and marketing materials. This course may be useful for anyone wanting to become a Medical Writer because of its detailed coverage of cancer signaling pathways and targeted therapies. The knowledge gained from the course about specific signaling pathways, the tumor microenvironment, and oncogenic mutations provide a strong foundation for writing about cancer drugs and therapies. The insights into clinical trial outcomes, FDA approvals, and the genomic segmentation of patients will allow you to create accurate and persuasive documents. Furthermore, the information about immune checkpoint inhibitors clinical applicability can make understanding new advances much easier to understand.
Pharmacovigilance Scientist
Pharmacovigilance Scientists monitor the safety of pharmaceutical products after they are marketed. If you wish to be a Pharmacovigilance Scientist, the course's discussion of targeted therapies and their side effects provides essential information for identifying and evaluating adverse events. The course's coverage of specific signaling pathways, oncogenic mutations, and the tumor microenvironment helps you understand the mechanisms of action of cancer drugs and their potential toxicities. Also, the course's discussion of clinical trial outcomes and FDA approvals gives you a real-world perspective on the safety profiles of cancer therapies. With a more concrete understanding about immune checkpoint inhibitors, one can keep up with the latest in cancer therapeutics.
Toxicologist
Toxicologists study the adverse effects of chemical substances on living organisms. A role as a Toxicologist may require an advanced degree. As a Toxicologist, this course's discussion of targeted therapies and their side effects provides valuable insights into the potential toxicities of cancer drugs. The coverage of specific signaling pathways and oncogenic mutations can help you understand the mechanisms of toxicity. Furthermore, the course's examination of the tumor microenvironment is crucial for understanding how cancer drugs interact with normal tissues and cells. This gives someone who desires to be a toxicologist a good understanding of some key oncological concepts. It will be particularly helpful to have a strong understanding of immune checkpoint inhibitors.
Clinical Research Associate
A Clinical Research Associate plays a crucial role in the execution of clinical trials, including those focused on cancer therapies. This course may be useful for anyone wanting to become a Clinical Research Associate due to its focus on targeted therapies and the challenges of translating lab findings to medical treatments. You will learn about specific signaling pathways and targeted therapies, as well as the genomic segmentation of patients for improved drug approval rates. The course content related to targeted therapies and their clinical applications helps build a strong understanding of the research landscape. Knowledge of the side effects of pathway inhibition, as discussed in the course, will make you more effective in monitoring patient safety during clinical trials. The discussion of immune checkpoint inhibitors clinical impacts the understanding of modern cancer research.
Science Writer
Science Writers communicate scientific information to a general audience or specialized groups such as healthcare professionals. This Science Writer course's emphasis on cancer signaling pathways and targeted therapies provides a great foundation for writing about cancer research and treatment. You can use the course's detailed coverage of pathways like MAPK and PI3K to explain complex scientific concepts in a clear and engaging manner. Also, the real-life examples from clinical trials can be used to illustrate the benefits and challenges of targeted therapies. The discussion on the shift towards genomic patient segmentation and its impact on drug approvals can provide a fresh perspective for articles and content. You will be able to use the information about immune checkpoint inhibitors and their clinical applications to create informed content for cancer advocates, patients, and other interested people.
Regulatory Affairs Specialist
Regulatory Affairs Specialists ensure that pharmaceutical products comply with regulations and guidelines set by regulatory agencies. As a Regulatory Affairs Specialist, the course's discussion of targeted therapies, clinical trials, and FDA approvals provides valuable insights into the regulatory landscape of cancer drugs. The course's focus on the shift from histological to genomic patient segmentation and its impact on drug approvals helps understand the current trends in the field. Understanding the challenges the medical field faces, as described in the course, is important for navigating the regulatory process. You may also be able to better understand the importance of data from clinical trials when it comes to drug approval. The section on immune checkpoint inhibitors and their clinical applications may give a clear view of new advances in the sector.
Clinical Data Manager
Clinical Data Managers are responsible for the collection, management, and integrity of clinical trial data. As a Clinical Data Manager, this course may be useful because it focuses on cancer signaling pathways and targeted therapies, so it helps you understand the context of clinical trials in oncology. The course's content relating to specific signaling pathways and oncogenic mutations can help you with quality checking and data validation. Furthermore, because the course discusses the challenges in the medical field, this can help you anticipate potential issues in data collection and reporting. Real life clinical trial examples will also help one prepare for challenges. Therefore, it will be useful to be aware of immune checkpoint inhibitors.
Pharmaceutical Sales Representative
Pharmaceutical Sales Representatives promote and sell pharmaceutical products, including cancer drugs, to healthcare professionals. This course may be useful for anyone considering becoming a Pharmaceutical Sales Representative because of its focus on targeted therapies, which are increasingly important in cancer treatment. The course's coverage of specific signaling pathways and their targeted therapies provides a scientific foundation for understanding the drugs you might be selling. The insights into clinical trial outcomes and the challenges faced in the medical field will help you communicate the value and limitations of cancer drugs to physicians. By learning about the genomic approach to patient segmentation, you can better understand which patients are most likely to benefit from specific treatments. The information about immune checkpoint inhibitors clinical trials is also beneficial.
Market Access Manager
Market Access Managers work to ensure that pharmaceutical products are accessible to patients by negotiating pricing and reimbursement with payers. As a Market Access Manager, the course's focus on targeted therapies and their clinical benefits provides valuable insights into the value proposition of cancer drugs. The course's discussion of clinical trial outcomes, FDA approvals, and the genomic segmentation of patients can help you make the case for reimbursement. Also, it is helpful to be aware of the challenges the medical field faces, so as to better understand the importance of new therapeutics. Furthermore, with a more concrete understanding of the clinical usage of immune checkpoint inhibitors, one can better advocate for new treatments.
Intellectual Property Analyst
Intellectual Property Analysts assess the patentability of inventions and monitor the intellectual property landscape in a particular field. This course may be useful for anyone wanting to be an Intellectual Property Analyst because of its focus on cancer signaling pathways and targeted therapies. The detailed exploration of specific pathways, oncogenic mutations, and targeted therapies will help understand the novelty and inventiveness of new cancer drugs and therapies. The course's insights into clinical trial outcomes, FDA approvals, and the genomic segmentation of patients will help you assess the commercial potential of new inventions. Furthermore, because of the discussion on immune checkpoint inhibitors, this is advantageous.

Reading list

We've selected two books that we think will supplement your learning. Use these to develop background knowledge, enrich your coursework, and gain a deeper understanding of the topics covered in Cancer Signaling Pathways and Targeted Therapy.
Expands on the original 'Hallmarks of Cancer' review article, providing a detailed overview of the key characteristics of cancer cells. It valuable resource for understanding the underlying principles that drive cancer development and progression. This book adds more depth to the course by providing a comprehensive framework for understanding the complexities of cancer biology and targeted therapies.
This Pulitzer Prize-winning book provides a comprehensive history of cancer research and treatment. It offers valuable context for understanding the challenges and triumphs in developing targeted therapies. The book is particularly helpful for appreciating the evolution of cancer treatment strategies, from broad cytotoxic approaches to more precise, pathway-specific interventions. It serves as excellent additional reading to deepen your understanding of the field.

Share

Help others find this course page by sharing it with your friends and followers:

Similar courses

Similar courses are unavailable at this time. Please try again later.
Our mission

OpenCourser helps millions of learners each year. People visit us to learn workspace skills, ace their exams, and nurture their curiosity.

Our extensive catalog contains over 50,000 courses and twice as many books. Browse by search, by topic, or even by career interests. We'll match you to the right resources quickly.

Find this site helpful? Tell a friend about us.

Affiliate disclosure

We're supported by our community of learners. When you purchase or subscribe to courses and programs or purchase books, we may earn a commission from our partners.

Your purchases help us maintain our catalog and keep our servers humming without ads.

Thank you for supporting OpenCourser.

© 2016 - 2025 OpenCourser